Andrew Hooper
About Andrew Hooper
Andrew Hooper is the Director of Commercial Manufacturing at Travere Therapeutics, where he has worked since 2014. He has extensive experience in the pharmaceutical manufacturing sector, having held various leadership roles at Sanofi-Aventis and Balboa Biosciences, and actively participates in non-profit organizations focused on youth and family services.
Work at Travere Therapeutics
Andrew Hooper has been serving as the Director of Commercial Manufacturing at Travere Therapeutics since 2014. In this role, he oversees manufacturing operations, ensuring compliance with industry regulations and standards. His responsibilities include managing production processes and implementing strategies to enhance operational efficiency. Hooper's tenure at Travere Therapeutics spans a decade, during which he has contributed to the company's growth and operational success.
Previous Experience at Sanofi-Aventis
Prior to joining Travere Therapeutics, Andrew Hooper held various positions at Sanofi-Aventis in North America from 1985 to 2004. He served as Manufacturing Head in Puerto Rico for seven years, followed by roles as North America Regional Director and Director of NA Industrial Technologies, overseeing eight manufacturing sites and more than 3,000 employees. His experience at Sanofi-Aventis included significant responsibilities in manufacturing operations and technology management.
Education and Expertise
Andrew Hooper earned a Bachelor of Science degree in Biology/Biological Sciences from Western University, where he studied from 1975 to 1978. He holds a Lean/Six Sigma Black Belt, which reflects his expertise in process improvement and operational excellence. His educational background and certifications support his extensive experience in manufacturing and technical services within the pharmaceutical industry.
Board Memberships and Community Involvement
Andrew Hooper serves as a board member for several non-profit organizations, focusing on youth residential programs and the Family Court Clinic. His involvement in these organizations highlights his commitment to community service and social responsibility. Additionally, he chairs the Corporate United Way Campaign, demonstrating leadership in corporate social responsibility initiatives within his professional environment.
Achievements in Manufacturing Compliance
Throughout his career, Andrew Hooper has been involved in various compliance initiatives, particularly in the areas of warning letter and consent decree remediation. He has successfully initiated serialization activities to ensure compliance with the Drug Supply Chain Security Act (DSCSA) and the Falsified Medicines Directive (FMD). His work in these areas has contributed to significant improvements in process performance and operational compliance in the pharmaceutical manufacturing sector.